Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

Genetic-based precision medicine holds promise

A type of personalized care known as precision medicine, and its subset, genomic medicine, is now the standard of care in Connecticut’s Hartford HealthCare Cancer Institute, UConn...

| By Kelley Gipson

BioCT stands with BLM

“Black Lives Matter and BioCT is committed to addressing racism through members’ employment practices, their development of therapeutics to benefit all patients and our support of...

| By Kelley Gipson

Pfizer establishes new innovation program

Pfizer is establishing the Pfizer Breakthrough Growth Initiative, through which Pfizer will invest up to $500 million in biotechnology companies to help provide funding and...

| By Kelley Gipson

CT bioscience a leader in fight against COVID-19

As Connecticut continues to face one of the world’s deadliest COVID-19 outbreaks, the state’s bioscience industry has aggressively turned its focus to developing new breakthrough...

| By Kelley Gipson

LambdaVision secures funding re artificial retina

LambdaVision has been selected by NASA for a Small Business Innovation Research (SBIR) Phase II award, worth $750,000 over two years. With the continued support...

| By Kelley Gipson

InveniAI in strategic partnership with TB Alliance

InveniAI® LLC has formed a strategic partnership with TB Alliance, a non-profit organization dedicated to the discovery, development, and delivery of better, faster-acting and affordable...

| By Kelley Gipson

BioCT welcomes Architectural Building Systems

Architectural Building Systems is a multi-generational General Contracting and Construction Management firm that was founded in 1985 to serve the ever-changing needs of customers in...

| By Kelley Gipson

101 College St project clears committee hurdle

Plans for a new 10-story, 500,000-square-foot bioscience building in downtown New Haven to feature lab, research, and incubator space have garnered a key approval. The...

| By Kelley Gipson

Sema4 and Tangen tackle COVID-19 testing

Tangen Biosciences and LabWare have agreed to enter into an  exclusive partnership whereby LabWare will distribute Tangen’s GeneSpark™ device as part of the LabWare’s Portable Disease...

| By Kelley Gipson

HBJ special: Leadership in a Time of Crisis

The Hartford Business Journal has produced a special online publication, Leadership in a Time of Crisis: Letters of inspiration and hope from the stae’s business...